Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ENDO INTERNATIONAL PLC ENDPQ

Healthcare Drug Manufacturers - Specialty & Generic
Endo International plc has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code and is winding down its business. The Company has no business operations.

Recent & Breaking News (GREY:ENDPQ)

Endo Completes Acquisition Of Auxilium Pharmaceuticals

Canada NewsWire January 29, 2015

Endo International plc Announces Pricing of Private Offering Of Senior Notes

Canada NewsWire January 21, 2015

Endo International plc Announces Proposed Private Offering Of Senior Notes

Canada NewsWire January 20, 2015

Endo Announces Changes to Senior Management Team

Canada NewsWire January 9, 2015

Endo Announces Retirement of Chief Legal Officer

Canada NewsWire January 5, 2015

Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain

Canada NewsWire December 23, 2014

Endo Announces Appearances at Upcoming Conferences

Canada NewsWire December 22, 2014

Endo Registration Statement Relating to Pending Auxilium Acquisition Declared Effective by the SEC

Canada NewsWire December 11, 2014

Endo Completes Acquisition of Rights to Natesto(TM) Testosterone Nasal Gel

Canada NewsWire December 9, 2014

Endo Acquires Rights to Natesto(TM) Testosterone Nasal Gel

Canada NewsWire November 24, 2014

Endo Announces Launch of Generic Version of Valcyte®

PR Newswire November 20, 2014

Endo Announces Early Termination of HSR Act Waiting Period in Connection with its Proposed Acquisition of Auxilium Pharmaceuticals

PR Newswire November 19, 2014

Endo Receives Final Approval for Generic Version of Valcyte®

PR Newswire November 10, 2014

Endo Reports Third Quarter Financial Results

PR Newswire November 5, 2014

Endo to Announce Third Quarter 2014 Financial Results on November 5, 2014

PR Newswire October 20, 2014

Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion

PR Newswire October 9, 2014

Endo Reaches Master Settlement Agreements to Resolve Substantially All Remaining AMS Mesh Litigation Claims

PR Newswire September 30, 2014

Endo International Comments On Auxilium Pharmaceutical's Rejection Of Its Acquisition Proposal

PR Newswire September 22, 2014

Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock

PR Newswire September 16, 2014

Top-Line Data Show the Investigational TOPAS(TM) System Improves Fecal Incontinence in Women

PR Newswire September 8, 2014